PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Nemera launches UniSpray, its unidose system primarily for systemic-acting drug administration

Nemera has a proven track record in developing and manufacturing complex Ear, Nose and Throat solutions. In line with clear growing market interest in unidose system...
Continue Reading →
News

Short term reshoring the catalyst for longer term manufacturing innovations by 2030

China and the USA predicted to lead innovation by 2030 in an age of mass personalized therapeutics, cobots, AI, and automation delivering process improvements Ams...
Continue Reading →
News

UK Government terminates COVID-19 vaccine agreement with Valneva

The French speciality vaccine company, Valneva, has announced that it has received a termination notice from the UK Government in relation to the Supply Agreement fo...
Continue Reading →
Volume 13 Issue 3

Biotech in China: Maximising the Global Opportunity

Pharmaceutical companies from China are showing an increasing interest in international market opportunities, focusing on new drug developments in the biological fie...
Continue Reading →
Volume 13 Issue 3

Current Trends in Formulation Development and Implications for Drug Delivery Devices

The market for parenteral drug-device combination products has been evolving over the last 15–20 years, developing innovation both on formulation and device design f...
Continue Reading →
News

WuXi STA and Antengene Sign Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Antengene Corporation, a biopharmaceutical company, recently announced a strateg...
Continue Reading →
News

CPhI report predicts new finished product manufacturing hub in the Middle East

Forgotten markets of Africa and Arabia to see increased growth fuelled by international & domestic partnerships and imported APIs A new report by CPhI forecasts ...
Continue Reading →
News

Almac Group Appoints David Taylor as Head of Manufacturing Operations

David Taylor joined the Almac Group in November 2017 as Head of Manufacturing, Almac Sciences.  He is tasked with the overall accountability for small molecul...
Continue Reading →
News

Phoenix Molecular Designs Announces Manufacturing Collaboration with WuXi STA to advance PMD-026 toward IND

MD-026 is the first RSK inhibitor to demonstrate potential disease-modifying properties in triple-negative breast cancer (TNBC)   Phoenix Molecular Designs (Pho...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026